"assets of the company" include several hundred thousand vials of the most precious stuff on earth right now. IP is NOT included. It's not rocket science... $50m of loan clateralized by billions worth of Leronlab isn't risky or stupid, on anyone's part, the financer or CytoDyn. Worst case, they make several multiples of their $50mil selling the LLMab and CYDY keeps the IP. Nobody loses.

Best case, approval means thousandaires turn into millionaires, and millionaires billionaires.